TESLA STOCKHOLDER ALERT: Levi & Korsinsky, LLP Announces a

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TESLA STOCKHOLDER ALERT: Levi & Korsinsky, LLP Announces a Lawsuit Against Elon Musk and Others Concerning Tesla’s Proposed Acquisition of SolarCity -- TSLA

NEW YORK, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that it filed a lawsuit on behalf of Tesla Motors, Inc. to challenge its proposed acquisition of SolarCity. The lawsuit alleges that Elon Musk and other conflicted Tesla directors, with the assistance of certain SolarCity directors, orchestrated Tesla’s acquisition of SolarCity to protect their personal investments in SolarCity, and Musk’s legacy in the solar energy industry.

According to the complaint, before the announcement of this deal, SolarCity was on the verge of collapse. If SolarCity fails, Musk and his family and friends, who are Tesla and SolarCity directors, will lose millions of dollars that they invested in SolarCity. In order to prevent these losses and protect their personal interests, Musk, Tesla’s CEO, Chairman and controlling stockholder, and the other Tesla and SolarCity directors forced Tesla to bailout SolarCity at a vastly inflated price. In fact, Musk, and his family and friends will collect nearly $1 billion of SolarCity’s purported $2.6 billion equity value while saddling Tesla with more than $3 billion of SolarCity’s debt. The SolarCity acquisition may also destroy Tesla’s future. Tesla is close to achieving its goal of mass producing an affordable electric car and becoming a profitable company, but it still faces many obstacles. Tesla, therefore, cannot afford the distraction of integrating a cash burning, non-core asset into the company.

To protect the interests of Tesla and its stockholders, Levi & Korsinsky, on behalf of Tesla, filed a lawsuit in the Delaware Court of Chancery challenging its proposed acquisition of SolarCity, and seeking all appropriate remedies. If you wish to join the lawsuit or obtain additional information, go to :

http://zlk.9nl.com/tesla

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com  or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004            Tel: (212) 363-7500 Toll Free:  (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PG&E's $500K Grants Wrap Up Five-Year Environmental Push

Updated Category News Views 45

Wrapping Up a Half-Decay of Environmental Commitment PG&E has been playing the long game with its environmental initiatives, and this wraps up a five-year saga that's worth dissecting. The PG&E Corporation Foundation has doled out its final set of grants, making a 25-strong lineup of eco-friendly campaigns. We're talking $500,000 split among five organizations trying to...

Continue Reading
Okta Joins S&P 500 Amidst Major Index Shuffles

Updated Category News Views 14

Okta Leaps to S&P 500: A Power Play You blink for a second, and boom, Okta's sitting at the big kids' table—the S&P 500. You know how rare that move is? It’s like snagging an invite to the party everyone wants to attend. Swapping out Kenvue Inc. (NYSE: KVUE), which Kimberly-Clark (NASD: KMB) is scooping up, Okta's maneuver signifies a hefty endorsement of its growth...

Continue Reading
BingX's AI Enjoys Roaring Adoption in Trading

Updated Category News Views 56

Traders and their AI tools—sounds like a match made in market heaven, right? That's the buzz coming out of BingX, the multi-asset trading platform that's been shaking things up in the fintech realm. These days, it seems like everyone's hitching a ride on the AI train. Explosive Growth in AI Utilization Now, let's talk numbers, and boy, are these numbers juicy. Daily...

Continue Reading
Visionary Animator Julian Glander to Speak at RMCAD

Updated Category News Views 44

Art Meets Animation: Glander's Inspiring Visit In the offbeat, winding world of creativity, Julian Glander's name rings some serious bells. This Pittsburgh-based powerhouse, known for his whimsical animations and illustrations, is heading to Rocky Mountain College of Art + Design (RMCAD) for the 2026/2027 Friction Series. It's happening November 10—pencil that in...

Continue Reading
Actinium Lures Talent with Inducement Stock Option

Updated Category News Views 39

New hires in biotech often get more than just a desk and a computer—they might just snag a piece of the company pie, too. Actinium Pharmaceuticals, the folks dabbling in the mysterious world of targeted radiotherapies, pulled a classic move in welcoming a fresh face to their roster. On October 26, 2026, they rolled out an inducement stock option, a juicy carrot to lure...

Continue Reading
SMTC: Thriving with Innovation in EMS Landscape

Updated Category News Views 34

Trailblazing in the Evolving EMS Arena SMTC's latest accolade from Frost & Sullivan isn't just another feather in their cap. It's a testament to how this mid-tier electronics manufacturing services (EMS) player stands head and shoulders above the rest. While other companies are fumbling with supply chain headaches and shifting market demands, these folks are buckling down...

Continue Reading
Investigation of Maplebear Sale to DoorDash Sparks Debate

Updated Category News Views 64

Shareholders Fret Over Maplebear's Proposed Transaction It ain't every day a deal's got shareholders fidgeting more than a cat in a dog park, but here we are. Maplebear Inc. (NASDAQ: CART) finds itself under the magnifying glass as the seasoned crew over at Monteverde & Associates PC sound the alarm bells. The firm, sitting cozy in the Empire State Building, is on the...

Continue Reading
ADT Shareholders Face Legal Scrutiny in M&A Deal

Updated Category News Views 19

ADT Shareholders on High Alert Listen up, folks. Anyone holding shares in ADT Inc. (NYSE: ADT) needs to sharpen their pencils and start crunching numbers. This isn't the time to sit back and coast. A M&A Class Action investigation is brewing, and it's centered on ADT's sale to Thrive Holdings. The $10.00 per share buyout offer might look neat and tidy, but there's more to...

Continue Reading
Blue Moon Metals Scraps Major Acquisition Plan

Updated Category News Views 73

Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...

Continue Reading
Cousins Lobster Hits Arkansas for Tasty Pop-Up Tour

Updated Category News Views 108

A New England Delicacy Rolling into Arkansas Folks in Northwest Arkansas are about to get a bite of the coast, and it's a big deal for any foodie out there who craves that authentic, no-frills lobster experience. Cousins Maine Lobster is setting out on a pop-up tour—a whirlwind of five days from November 11-15—bringing their joy-inducing lobster rolls straight from...

Continue Reading

Top 5 Most Recently Viewed Articles

Olema Oncology Unveils Exciting Progress on Palazestrant Updates

Updated Category News Views 116

Exciting Updates on Palazestrant and Ribociclib Combination Recent discussions revolving around Palazestrant, especially in conjunction with ribociclib, have unveiled promising clinical activities. Patients suffering from estrogen receptor-positive and human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer have shown significant...

Continue Reading
Innovative Tri-Specific Antibody Platform by Purple Biotech

Updated Category News Views 178

Introduction to Purple Biotech and CAPTN-3 Purple Biotech is making significant strides in the field of cancer therapy with its innovative tri-specific antibody platform known as CAPTN-3. This technology employs a conditionally activated mechanism that engages T cells and NK cells, which are crucial components of the immune system, to enhance the body’s ability to fight...

Continue Reading
Key Steps for Xerox Holdings Corp Shareholders Regarding Class Action

Updated Category News Views 99

Important Information for Shareholders of Xerox Holdings Corporation New York, November 26, 2024 - The Gross Law Firm is reaching out to shareholders of Xerox Holdings Corporation (NASDAQ: XRX) to discuss potential class actions related to recent events. This notice is essential for investors who purchased XRX shares within a specified timeframe. Why Contact The Gross Law...

Continue Reading
Exploring the Potential Surge of RTX Stock in 2026

Updated Category News Views 140

Understanding RTX's Impressive Stock Surge RTX (NYSE: RTX) stock is experiencing a notable rise in early 2026, buoyed by strong performance levels and significant capital returns. The defense and aerospace leader appears poised for further gains, as projections for 2026 indicate a robust uptrend. The defense sector has shown remarkable strength, sustaining growth...

Continue Reading
Investing in Carlisle Companies: A Journey of Growth

Updated Category News Views 159

Unveiling the Growth of Carlisle Companies Carlisle Companies, identified by ticker CSL, has demonstrated an exceptional performance in the stock market over the past five years. With an impressive annualized return of 25.83%, its growth trajectory outpaces the average market performance by 11.8%. As of now, the company's market capitalization stands at a notable $16.34...

Continue Reading